Improved Glycaemia Correlates with Liver Fat Reduction in Obese, Type 2 Diabetes, Patients Given Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
Purity and safety are guaranteed
Obesity rates in the UK have risen steadily for decades, with around two thirds of adults now overweight or obese
"The FDA submission of CagriSema marks an important milestone and signals a new era in weight management, reinforcing Novo Nordisk's long-standing commitment to serving people living with obesity through innovation and science," said Mike Doustdar, president and CEO of Novo Nordisk
This helps regulate blood sugar levels, decrease appetite, and promote healthy weight loss
making it easier for your body to shed excess weight